How Does SPRINT (Systolic Blood Pressure Intervention Trial) Direct Hypertension Treatment Targets for CKD?

被引：6
|
作者：
Taler, Sandra J. [1 ]
机构：
[1] Mayo Clin, Rochester, MN USA
来源：
AMERICAN JOURNAL OF KIDNEY DISEASES | 2016年 / 68卷 / 01期
关键词：
RENAL-DISEASE; NEPHROPATHY; PROGRESSION; IRBESARTAN; OUTCOMES;
D O I：
10.1053/j.ajkd.2016.02.045
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：15 / 18
页数：4
相关论文
共 50 条
  • [21] Intensive systolic blood pressure treatment remodels brain perivascular spaces: A secondary analysis of the Systolic Pressure Intervention Trial (SPRINT)
    Kern, Kyle C.
    Nasrallah, Ilya M.
    Bryan, Robert Nick
    Reboussin, David M.
    Wright, Clinton B.
    NEUROIMAGE-CLINICAL, 2023, 40
  • [22] The Tale of an Innocent Intensive Treatment and the J-Curve in the SPRINT Trial (Systolic Blood Pressure Intervention Trial)
    Verdecchia, Paolo
    Angeli, Fabio
    Reboldi, Gianpaolo
    CIRCULATION, 2017, 136 (23) : 2230 - U262
  • [23] Intensive Blood Pressure Treatment and Subclinical Brain Infarcts: A Secondary Analysis of SPRINT (Systolic Pressure Intervention Trial)
    Kern, Kyle C.
    Nasrallah, Ilya M.
    Bryan, R. Nick
    Williamson, Jeff
    Reboussin, David M.
    Pajewski, Nicholas M.
    Wright, Clinton B.
    ANNALS OF NEUROLOGY, 2024, 95 (05) : 866 - 875
  • [24] Resistant Hypertension: Insights on Evaluation and Management in the Post-SPRINT (Systolic Blood Pressure Intervention Trial) Era
    Townsend, Raymond R.
    Epstein, Murray
    HYPERTENSION, 2016, 68 (05) : 1073 - 1080
  • [25] Unobserved automated office blood pressure measurement in the Systolic Blood Pressure Intervention Trial (SPRINT): systolic blood pressure treatment target remains below 140 mmHg
    Kjeldsen, Sverre E.
    Mancia, Giuseppe
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY, 2016, 2 (02) : 79 - +
  • [26] EFFECT OF INTENSIVE VERSUS STANDARD BLOOD PRESSURE TREATMENT ACCORDING TO BASELINE SYSTOLIC BLOOD PRESSURE: A POST HOC ANALYSIS OF SPRINT (SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL)
    Sun Xiuting
    Xiaodong Zhuang
    Liao, Xinxue
    JOURNAL OF HYPERTENSION, 2018, 36 : E115 - E116
  • [27] EFFECT OF INTENSIVE VERSUS STANDARD BLOOD PRESSURE TREATMENT ACCORDING TO BASELINE SYSTOLIC BLOOD PRESSURE: A POST HOC ANALYSIS OF SPRINT (SYSTOLIC BLOOD PRESSURE INTERVENTION TRIAL)
    Zhuang, Xiaodong
    Sun, Xiuting
    Du, Zhimin
    Liao, Xinxue
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 1916 - 1916
  • [28] Data-driven cluster analysis of hypertension and their association with cardiovascular outcomes and treatment effects: Systolic Blood Pressure Intervention Trial (SPRINT)
    Zhuang, Xiaodong
    Liao, Lizhen
    Nie, Zhiqiang
    Yang, Daya
    Zhang, Shaozhao
    Zhou, Huimin
    Sun, Xiuting
    Zhong, Xiangbin
    Du, Zhimin
    Liao, Xinxue
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (16) : C153 - C154
  • [29] Baseline and on-treatment serum bicarbonate, intensive blood pressure lowering, and mortality: the Systolic Blood Pressure Intervention Trial (SPRINT)
    Pareek, M.
    Byrne, C.
    Vaduganathan, M.
    Biering-Sorensen, T.
    Krogager, M. L.
    Kragholm, K. H.
    McCullough, M.
    Desai, N. R.
    Olsen, M. H.
    Bhatt, D. L.
    EUROPEAN HEART JOURNAL, 2020, 41 : 2731 - 2731
  • [30] Biomarkers of Kidney Tubule Health, CKD Progression, and Acute Kidney Injury in SPRINT (Systolic Blood Pressure Intervention Trial) Participants
    Bullen, Alexander L.
    Katz, Ronit
    Jotwani, Vasantha
    Garimella, Pranav S.
    Lee, Alexandra K.
    Estrella, Michelle M.
    Shlipak, Michael G.
    Ix, Joachim H.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2021, 78 (03) : 361 - +
12345